Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29911088 | 1.00 | CYP3A4 (0.44) | CYP3A4ALDH1A1LMNAESR1ESR2 | |
| SCHEMBL1360287 | 0.77 | RXRA (0.49) | CYP3A4ALDH1A1LMNATP53CYP1A2 | |
| SCHEMBL30701838 | 0.77 | RXRA (0.49) | CYP3A4ALDH1A1LMNATP53CYP1A2 | |
| SCHEMBL7106142 | 0.77 | RARB (0.40) | CYP3A4ALDH1A1LMNAESR1ESR2 | |
| SCHEMBL10899122 | 0.77 | RARB (0.50) | ESR1ESR2OPRM1OPRD1OPRK1 | |
| SCHEMBL7106913 | 0.75 | RARB (0.42) | CYP3A4ALDH1A1LMNAESR1ESR2 | |
| SCHEMBL11052113 | 0.75 | CYP3A4 (0.43) | CYP3A4ALDH1A1LMNAESR1ESR2 | |
| SCHEMBL11058779 | 0.75 | CYP3A4 (0.43) | CYP3A4ALDH1A1LMNAESR1ESR2 | |
| SCHEMBL11052109 | 0.75 | CYP3A4 (0.43) | CYP3A4ALDH1A1LMNAESR1ESR2 | |
| SCHEMBL11052108 | 0.75 | CYP3A4 (0.43) | CYP3A4ALDH1A1LMNAESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| WO-2004026810-A1 | TRICYCLO[6.2.2]DODECA-2(7),3,5-TRIEN-4-CARBONYL)AMINO]-DERIVATIVES HAVING RAR-ALPHA- RECEPTOR SELECTIVE BIOLOGICAL ACTIVITY | ALLERGAN, INC. (US) | 2004-04-01 | — | — | WO | disclosed |
| US-6620963-B1 | Secondary carbocyclic amides, having preferential binding to retinoid acid receptors (RAR), used for prophylaxis of skin disorders and as topical microbiocides | ALLERGAN, INC. | 2003-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | CRY1, CRY2, LEF1 | CYP3A4 27/4885ALDH1A1 26/4885LMNA 2441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.